Cargando…
Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654583/ https://www.ncbi.nlm.nih.gov/pubmed/34895486 http://dx.doi.org/10.1016/j.ccell.2021.12.003 |
_version_ | 1784611892442955776 |
---|---|
author | Konishi, Yoshinobu Sklavenitis-Pistofidis, Romanos Yue, Hong Ferrari, Federico Redd, Robert A. Lightbody, Elizabeth D. Russo, Massimiliano Perry, Jacqueline Horowitz, Erica Justis, Anna V. Shayegh, Nader A. Savell, Alexandra Prescott, Julia Varmeh, Shohreh Nowak, Radosław P. Hamilton, Mark Auclair, Daniel Marinac, Catherine R. Trippa, Lorenzo Fischer, Eric S. Ghobrial, Irene M. |
author_facet | Konishi, Yoshinobu Sklavenitis-Pistofidis, Romanos Yue, Hong Ferrari, Federico Redd, Robert A. Lightbody, Elizabeth D. Russo, Massimiliano Perry, Jacqueline Horowitz, Erica Justis, Anna V. Shayegh, Nader A. Savell, Alexandra Prescott, Julia Varmeh, Shohreh Nowak, Radosław P. Hamilton, Mark Auclair, Daniel Marinac, Catherine R. Trippa, Lorenzo Fischer, Eric S. Ghobrial, Irene M. |
author_sort | Konishi, Yoshinobu |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8654583 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86545832021-12-09 Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia Konishi, Yoshinobu Sklavenitis-Pistofidis, Romanos Yue, Hong Ferrari, Federico Redd, Robert A. Lightbody, Elizabeth D. Russo, Massimiliano Perry, Jacqueline Horowitz, Erica Justis, Anna V. Shayegh, Nader A. Savell, Alexandra Prescott, Julia Varmeh, Shohreh Nowak, Radosław P. Hamilton, Mark Auclair, Daniel Marinac, Catherine R. Trippa, Lorenzo Fischer, Eric S. Ghobrial, Irene M. Cancer Cell Letter Elsevier Inc. 2022-01-10 2021-12-09 /pmc/articles/PMC8654583/ /pubmed/34895486 http://dx.doi.org/10.1016/j.ccell.2021.12.003 Text en © 2021 Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter Konishi, Yoshinobu Sklavenitis-Pistofidis, Romanos Yue, Hong Ferrari, Federico Redd, Robert A. Lightbody, Elizabeth D. Russo, Massimiliano Perry, Jacqueline Horowitz, Erica Justis, Anna V. Shayegh, Nader A. Savell, Alexandra Prescott, Julia Varmeh, Shohreh Nowak, Radosław P. Hamilton, Mark Auclair, Daniel Marinac, Catherine R. Trippa, Lorenzo Fischer, Eric S. Ghobrial, Irene M. Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia |
title | Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia |
title_full | Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia |
title_fullStr | Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia |
title_full_unstemmed | Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia |
title_short | Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia |
title_sort | attenuated response to sars-cov-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and waldenstrom macroglobulinemia |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654583/ https://www.ncbi.nlm.nih.gov/pubmed/34895486 http://dx.doi.org/10.1016/j.ccell.2021.12.003 |
work_keys_str_mv | AT konishiyoshinobu attenuatedresponsetosarscov2vaccineinpatientswithasymptomaticprecursorstagesofmultiplemyelomaandwaldenstrommacroglobulinemia AT sklavenitispistofidisromanos attenuatedresponsetosarscov2vaccineinpatientswithasymptomaticprecursorstagesofmultiplemyelomaandwaldenstrommacroglobulinemia AT yuehong attenuatedresponsetosarscov2vaccineinpatientswithasymptomaticprecursorstagesofmultiplemyelomaandwaldenstrommacroglobulinemia AT ferrarifederico attenuatedresponsetosarscov2vaccineinpatientswithasymptomaticprecursorstagesofmultiplemyelomaandwaldenstrommacroglobulinemia AT reddroberta attenuatedresponsetosarscov2vaccineinpatientswithasymptomaticprecursorstagesofmultiplemyelomaandwaldenstrommacroglobulinemia AT lightbodyelizabethd attenuatedresponsetosarscov2vaccineinpatientswithasymptomaticprecursorstagesofmultiplemyelomaandwaldenstrommacroglobulinemia AT russomassimiliano attenuatedresponsetosarscov2vaccineinpatientswithasymptomaticprecursorstagesofmultiplemyelomaandwaldenstrommacroglobulinemia AT perryjacqueline attenuatedresponsetosarscov2vaccineinpatientswithasymptomaticprecursorstagesofmultiplemyelomaandwaldenstrommacroglobulinemia AT horowitzerica attenuatedresponsetosarscov2vaccineinpatientswithasymptomaticprecursorstagesofmultiplemyelomaandwaldenstrommacroglobulinemia AT justisannav attenuatedresponsetosarscov2vaccineinpatientswithasymptomaticprecursorstagesofmultiplemyelomaandwaldenstrommacroglobulinemia AT shayeghnadera attenuatedresponsetosarscov2vaccineinpatientswithasymptomaticprecursorstagesofmultiplemyelomaandwaldenstrommacroglobulinemia AT savellalexandra attenuatedresponsetosarscov2vaccineinpatientswithasymptomaticprecursorstagesofmultiplemyelomaandwaldenstrommacroglobulinemia AT prescottjulia attenuatedresponsetosarscov2vaccineinpatientswithasymptomaticprecursorstagesofmultiplemyelomaandwaldenstrommacroglobulinemia AT varmehshohreh attenuatedresponsetosarscov2vaccineinpatientswithasymptomaticprecursorstagesofmultiplemyelomaandwaldenstrommacroglobulinemia AT nowakradosławp attenuatedresponsetosarscov2vaccineinpatientswithasymptomaticprecursorstagesofmultiplemyelomaandwaldenstrommacroglobulinemia AT hamiltonmark attenuatedresponsetosarscov2vaccineinpatientswithasymptomaticprecursorstagesofmultiplemyelomaandwaldenstrommacroglobulinemia AT auclairdaniel attenuatedresponsetosarscov2vaccineinpatientswithasymptomaticprecursorstagesofmultiplemyelomaandwaldenstrommacroglobulinemia AT marinaccatheriner attenuatedresponsetosarscov2vaccineinpatientswithasymptomaticprecursorstagesofmultiplemyelomaandwaldenstrommacroglobulinemia AT trippalorenzo attenuatedresponsetosarscov2vaccineinpatientswithasymptomaticprecursorstagesofmultiplemyelomaandwaldenstrommacroglobulinemia AT fischererics attenuatedresponsetosarscov2vaccineinpatientswithasymptomaticprecursorstagesofmultiplemyelomaandwaldenstrommacroglobulinemia AT ghobrialirenem attenuatedresponsetosarscov2vaccineinpatientswithasymptomaticprecursorstagesofmultiplemyelomaandwaldenstrommacroglobulinemia |